← Entities
Public Body
Centro Hospitalar Universitário Cova da Beira, EPE
NIF 506361659
· PT
Risk Flags
A1 · Repeat Direct Award
€6,898,070
402 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH
€6,898,070
402 contracts
A2 · Late Publication
€163,099,146
3,803 contracts
Contract published to BASE more than 10 days after the signing date
LOW
€163,099,146
3,803 contracts
A5 · Threshold Splitting
€3,327,095
118 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH
€3,327,095
118 contracts
A9 · Price Overrun
€193,637
6 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH
€58,924
2 contracts
MEDIUM
€134,713
4 contracts
A9 · Abnormal Price Reduction
€80,167,940
2,794 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW
€80,167,940
2,794 contracts
B5 · Benford's Law Deviation
€194,548,513
4,550 contracts
Entity's contract values deviate from the Benford leading-digit distribution (chi-square goodness-of-fit, min 20 contracts). Score: 35 (p<0.05) or 55 (p<0.01).
MEDIUM
€194,548,513
4,550 contracts
Procurement Network
Aggregated links between this entity and connected counterparties
Public view excludes person-level links and tax identifiers.
Loading network…
No connections found for the current filters.
Legend
Focus entity
Public body
Company
Anonymized individual
Signal:
All
A1 · Repeat Direct Award
A2 · Late Publication
A5 · Threshold Splitting
A9 · Price Overrun
A9 · Abnormal Price Reduction
B5 · Benford's Law Deviation
C1 · Missing Supplier NIF
C3 · Missing Mandatory Fields
Page 1 of 1 · 6 results
AD 08-23 Aquisição do Medicamento Ustecinumab [90 Mg; Sol Inj; Seringa]
PT · 9780819
A9 · Price Overrun
A2 · Late Publication
JANSSEN - CILAG FAR...
Ao abrigo de acor...
€24,096
2023-01-25
€24,096
2023-01-25
AD 76-22 Aquisição do Medicamento APALUTAMIDA [60 MG; CÁP/COMP]
PT · 9576983
A9 · Price Overrun
A2 · Late Publication
JANSSEN - CILAG FAR...
Ao abrigo de acor...
€14,679
2022-11-10
€14,679
2022-11-10
Aquisição Medicamento RAMUCIRUMAB 10MG/ML;50ML;SOL INJ;FRS
PT · 9429748
A9 · Price Overrun
LILLY-PORTUGAL PROD...
Ao abrigo de acor...
€17,324
2022-08-26
€17,324
2022-08-26
Aquisição de Envelopes
PT · 5475379
A9 · Price Overrun
A2 · Late Publication
ENVELOPRINTER - TIP...
Concurso público
€4,620
2019-01-10
€4,620
2019-01-10
CP 15-18 Aquisição reagentes e consumíveis para determinação do exame sumário de urina (urina tipo II) e sedimento urinário
PT · 5205582
A9 · Price Overrun
A2 · Late Publication
MENARINI DIAGNOSTIC...
Concurso público
€17,000
2019-01-03
€17,000
2019-01-03
CPR 09/18 - Aquisição de Trouxas e Campos Cirúrgicos
PT · 5532184
A9 · Price Overrun
A5 · Threshold Splitting
+1
Medline
Consulta Prévia
€19,067
2018-07-26
€19,067
2018-07-26
Overview
Total Contracts
5,450
Score 208505 · CRITICAL RISK
Digit Distribution
n = 4,550 contracts
· χ² = 20.7635
1
30.8%
2
19.1%
3
12.6%
4
9.3%
5
6.7%
6
7.1%
7
5.4%
8
4.9%
9
4.1%
Observed
Expected (Benford)